Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


pX330S-5 Citations (2)

Originally described in: Multiplex genome engineering in human cells using all-in-one CRISPR/Cas9 vector system.
Sakuma T, Nishikawa A, Kume S, Chayama K, Yamamoto T Sci Rep. 2014 Jun 23;4:5400. doi: 10.1038/srep05400.
PubMed Journal

Articles Citing pX330S-5

Multiplexed tat-Targeting CRISPR-Cas9 Protects T Cells from Acute HIV-1 Infection with Inhibition of Viral Escape. Ophinni Y, Miki S, Hayashi Y, Kameoka M. Viruses. 2020 Oct 28;12(11). pii: v12111223. doi: 10.3390/v12111223. PubMed
Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer. Nargund AM, Xu C, Mandoli A, Okabe A, Chen GB, Huang KK, Sheng T, Yao X, Teo JMN, Sundar R, Kok YJ, See YX, Xing M, Li Z, Yong CH, Anand A, A I ZF, Poon LF, Ng MSW, Koh JYP, Ooi WF, Tay ST, Ong X, Tan ALK, Grabsch HI, Fullwood MJ, Teh TB, Bi X, Kaneda A, Li S, Tan P. Cancer Res. 2022 Jul 18;82(14):2538-2551. doi: 10.1158/0008-5472.CAN-21-2072. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.